Abu Dhabi, 28 April 2026: PureHealth, the largest healthcare group in the Middle East, has achieved full accreditation from the Association for the Accreditation of Human Research Protection Programs (AAHRPP) for its SEHA and Sheikh Shakhbout Medical City (SSMC) entities, recognising the strength of the group’s clinical research capabilities.

The research divisions of both entities operate under the Abu Dhabi Health Research Centre (ADHRC), PureHealth’s integrated clinical research hub, which consolidates activity across 16 hospitals, primary care clinics and advanced laboratories in Abu Dhabi. With more than 200 active studies spanning early and advanced clinical trials, as well as translational research, ADHRC is underpinned by a unified governance framework that strengthens oversight and enables high-quality research at scale.

2024 Sustainability Report highlights strong year-on-year gains across key ESG metrics and progress towardsthe Group’s Net Zero by 2040 goal

Abu Dhabi, UAE – 21October 2025: PureHealth, the largest healthcare group in the Middle East, has set new benchmarks for sustainable healthcare, achievingmeasurable progress in climate action, social impact, workforce empowerment and national value creation, as detailed in its newly published 2024 Sustainability Report. The Group secured the highest possibleenvironmental, social and governance (ESG) rating – AAA –from independent index provider MSCI, placing it among the top 10% of healthcare organisations globallyfor sustainability performance.

• AGM approves final dividend of AED 343 million for 2024, reflecting a payout of AED 3.09 fils per share, reaffirming PureHealth’s commitment to shareholder returns
• Proposed payout represents 20% of net profit for the 2024 financial year, underscored by Group’s revenue growth (58% YoY) & robust balance sheet

Abu Dhabi, 10 April 2025 – PureHealth Holding PJSC (“PureHealth” or “the Group”) (ADX Symbol: PUREHEALTH), the largest healthcare group in the Middle East, has announced, following its Annual General Assembly (AGM), shareholder approval for its first-ever dividend distribution since listing on the Abu Dhabi Securities Exchange (ADX) in December 2023. The final dividend as recommended by PureHealth’s Board of Directors amounts to a total of AED 343 million (AED 3.09 fils per share) for the 2024 financial year, representing 20% of the Group’s net profit.